Table 1.
Clinical and Epidemiological Findings of IHMAG Among 79 Patients.
| Characteristics | Value (%) |
|---|---|
|
| |
| Sex | |
| Male | 23 (29.1) |
| Female | 56 (70.9) |
|
| |
| Morphologic subtype | |
| Focal | 53 (67.1) |
| Segmental | 26 (32.9) |
|
| |
| Anatomic distribution | |
| Head and neck | 5 (6.3) |
| Trunk | 21 (26.6) |
| Limb | 37 (46.8) |
| Hand/foot | 16 (20.3) |
|
| |
| Presence of proliferation | |
| Yes | 32 (40.5) |
| No | 47 (59.5) |
|
| |
| Complications | |
| Ulceration | 3 (3.8) |
| Soft tissue hypertrophy | 2 (2.5) |
| Soft tissue hypotrophy | 3 (3.8) |
| Spinal dysraphism | 2 (2.5) |
| PHACE syndrome | 1 (1.3) |
| LUMBAR syndrome | 2 (2.5) |
| No complications | 66 (83.6) |
|
| |
| Associated anomalies | |
| Infantile hemangioma | 7 (8.9) |
| Vascular malformation | 5 (6.3) |
| No other associated anomalies | 67 (84.8) |
|
| |
| Systemic treatment | |
| Yes | 13 (16.5) |
| No | 66 (83.5) |
IHMAG: = infantile hemangiomas with minimal or arrested growth.